You have 9 free searches left this month | for more free features.

Condition

Acute Pyelonephritis (1)

COPD Exacerbation Acute (1)

Infection Due to Escherichia Coli (1)

Tuberculosis, Pulmonary (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Daiichi Sankyo, Inc. (1)

First Affiliated Hospital of Zhejiang University (1)

Mahidol University (1)

Collaborator

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

sitafloxacin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting

Tuberculosis, Pulmonary

Sitafloxacin
+7 more

(no location specified)

Jul 7, 2022

COPD Exacerbation Acute Trial in China (Sitafloxacin, Moxifloxacin Hydrochloride)

Recruiting

COPD Exacerbation Acute

Sitafloxacin
Moxifloxacin Hydrochloride

Changsha, China
+12 more

Sep 6, 2022

Infection Due to Escherichia Coli, Acute Pyelonephritis Trial in Bangkok (Sitafloxacin, Ertapenem)

Unknown status

Infection Due to Escherichia Coli
Acute Pyelonephritis

Sitafloxacin
Ertapenem

Bangkok, Thailand

Faculty of Medicine Ramathibodi Hospital

Aug 28, 2015